Investigation Overview
An investigation on behalf of investors in shares of Aevi Genomic Medicine, Inc. (NASDAQ: GNMX) was announced over potential breaches of fiduciary duties by certain officers and directors at Aevi Genomic Medicine, Inc. The investigation by a law firm concerns whether certain Aevi Genomic Medicine directors breached their fiduciary duties and caused damage to the company and its share...
You must register (for free) or login to view the entire investigation.